Sasol sale delayed
- Sasol mulls divestment of alkylates. // European Chemical News;9/15/2003, Vol. 79 Issue 2068, p9
Reports the plans of chemical company Sasol to divest its alkylates business in 2003. Factor that influenced the disinvestment plan; Earnings expected from the move; Financial performance of the other business units of Sasol.
- Rhodia near end of unit sales. Beacham, Will // European Chemical News;6/14/2004, Vol. 80 Issue 2104, p7
Reports that divestment of Rhodia's phosphate specialties business in the U.S. is in its final stages as of June 2004. Value of divestments achieved by the company since the beginning of 2004; Sale of its food ingredients business to Denmark's Danisco; Total annual sales of Rhodia's specialty...
- Sasol to offload subsidiary. // European Chemical News;11/3/2003, Vol. 79 Issue 2075, p8
Reports on the plan of South African energy and chemicals group Sasol to sell its Dutch speciality chemicals subsidiary, Sasol Servo, as of November 2003. Reason behind the sale; Worth of operating profits produced by the subsidiary; Focus of the business operation of Sasol.
- Sasol Seeks Exit From Petrochemicals JV in Iran. Alperowicz, Natasha // Chemical Week;4/30/2012, Vol. 174 Issue 12, p15
The article reports that Sasol is seeking to divest its stake in the petrochemicals joint venture (JV) Arya Sasol Polymers in Assaluyeh, Iran. The JV is equally owned by Pars Petrochemical Co., which is a subsidiary of National Petrochemical Co. (NPC) in Tehran, Iran. Officials at Sasol cite...
- Mergers & Acquisitions. Simpson, Wayne A. // Enterprise/Salt Lake City;5/8/2006, Vol. 35 Issue 44, p6
The author discusses issues related to the sale of business enterprises. He argues that deciding whether to sell a business enterprise is a difficult one and raises several questions on the part of a business owner. The reasons for selling a business as well as the reasons not to sell are also...
- SDC Worldwide Mergers & Acquisitions. // Mergers & Acquisitions Report;6/21/2004, Vol. 17 Issue 25, p7
Provides information on several worldwide mergers and acquisitions as of June 21, 2004. Summary of U.S. public merger activity greater than $50 million; Private targets greater than $50 million; Divestitures greater than $50 million.
- Cardinal Plans To Sell Large Unit. J. R. C. // Mergers & Acquisitions Report;12/11/2006, Vol. 19 Issue 47, p5
This article reports on the plan of Cardinal Health Inc. to sell its Pharmaceutical Technologies and Services (PTS) unit. The unit contributes to a little over 10% of the company's revenue. Cardinal Health will keep the Martindale and Beckloff Associates operations within PTS. Chief Financial...
- LUBRIZOL TO SELL DRUG INGREDIENTS BIZ. Bennett, David // Crain's Cleveland Business;4/3/2006, Vol. 27 Issue 14, p1
The article reports on the sale of Lubrizol Corp.'s pharmaceutical ingredient and compounds business, to a German private equity firm. Terms weren't disclosed. It would be the fifth divestiture since Wickliffe-based Lubrizol announced its intent to sell noncore businesses.
- UCB Dumps 50+ Programs in $667M Deal with GSK. // BioWorld Today;1/26/2009, Vol. 20 Issue 15, p2
The article reports on the decision of UCB SA to divest its smaller business operations, reaching a deal to sell more than 50 such programs to GlaxoSmithKline PLC for 515 million euro. Included in the acquisition deal are UCB operations in the Far East, Middle East, Latin America and Africa. UCB...